About this trial

This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to develop an enduring tool to allow for collaborative research between clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration will allow resources to be available to clinical and basic researchers alike. This tool will enable research of vascular disease in the Vascular Lab and will leverage this valuable asset to the fullest extent to allow for interdepartmental collaboration.

Eligibility criteria

Qualifiers

18 years or older

Subjects capable of providing informed consent document

Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases

Disqualifiers

Known life expectancy of ≤ 6 months at the time of enrollment

Known current pregnancy

Severe Anemia (last documented hemoglobin < 7.0 g/dL)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Cleveland Clinic44195, ClevelandOhio, United States

Sponsors and collaborators

The Cleveland Clinic

Lead sponsor